SAN DIEGO (AP) _ Regulus Therapeutics Inc. (RGLS) on Thursday reported a loss of $10.3 million in its third quarter.
The San Diego-based company said it had a loss of $1.18 per share.
The biopharmaceutical company posted revenue of $18,000 in the period.
In the final minutes of trading on Thursday, the company's shares hit $1.77. A year ago, they were trading at $11.29.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGLS at https://www.zacks.com/ap/RGLS